CompuMed (OTCMKTS:CMPD) Issues Earnings Results

CompuMed (OTCMKTS:CMPD) announced its quarterly earnings results on Monday. The company reported ($0.06) EPS for the quarter, Zacks reports. CompuMed had a negative net margin of 0.78% and a negative return on equity of 1.88%.

CompuMed Price Performance

CompuMed stock remained flat at $6.75 during midday trading on Monday. The company had a trading volume of 320 shares, compared to its average volume of 477. The business’s 50 day moving average price is $6.22 and its two-hundred day moving average price is $4.59. CompuMed has a 52 week low of $1.95 and a 52 week high of $6.95. The company has a market cap of $8.98 million, a PE ratio of -134.97 and a beta of -0.53. The company has a current ratio of 2.04, a quick ratio of 2.01 and a debt-to-equity ratio of 0.16.

CompuMed Company Profile

CompuMed, Inc, an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.